Plasma levels from head and neck cancer patients with and without cachexia showed a decrease in miR-130a levels with an increase in TNF-α levels that was highly specific to individuals with cachexia, demonstrating potential as a cancer cachexia biomarker [110]. This evidence concerns the gene TNF and cancer.